Show simple item record

dc.contributor.authorWheeler, Amandaen_US
dc.date.accessioned2017-05-03T11:49:16Z
dc.date.available2017-05-03T11:49:16Z
dc.date.issued2006en_US
dc.date.modified2011-08-02T08:26:44Z
dc.identifier.issn1175-8716en_US
dc.identifier.urihttp://hdl.handle.net/10072/39670
dc.description.abstractAim To outline the prescribing patterns of atypical antipsychotics for adult mental health outpatients in Auckland and Northland in 2004. Methods All community files were reviewed retrospectively (n=6165). Patient characteristics, diagnosis, and antipsychotic and concurrent medication were recorded and analysed. Results Overall, 71.3% of outpatients were prescribed an antipsychotic, of which 82.5% were atypicals: oral risperidone (30.9%), olanzapine (30.3%), quetiapine (17.1%), clozapine (26.3%), and depot risperidone (0.4%). Psychotic disorders accounted for 73.2% of outpatients on atypicals, and schizophrenia was the most common disorder overall (62.5%). Combination antipsychotic treatment occurred in 13.5% of those prescribed atypicals; 4.8% had another atypical and 8.7% had a typical co-prescribed. Clozapine was least likely to be combined with a typical antipsychotic. Those receiving combination typical and atypical antipsychotics had a greater likelihood of being prescribed an anticholinergic medication. Conclusions Atypical antipsychotics are the preferred treatment for outpatients with psychotic illness and are being prescribed in a manner consistent with clinical practice guidelines. Co-prescribing of antipsychotics was low, but may be causing unnecessary adverse effects and risks.en_US
dc.description.peerreviewedYesen_US
dc.description.publicationstatusYesen_AU
dc.format.extent132107 bytes
dc.format.mimetypeapplication/pdf
dc.languageEnglishen_US
dc.language.isoen_AU
dc.publisherNew Zealand Medical Associationen_US
dc.publisher.placeNew Zealanden_US
dc.publisher.urihttp://journal.nzma.org.nz/journal/119-1237/2055/en_AU
dc.relation.ispartofstudentpublicationNen_AU
dc.relation.ispartofpagefrom1en_US
dc.relation.ispartofpageto9en_US
dc.relation.ispartofissue1237en_US
dc.relation.ispartofjournalNew Zealand Medical Journalen_US
dc.relation.ispartofvolume119en_US
dc.rights.retentionYen_AU
dc.subject.fieldofresearchMedical and Health Sciences not elsewhere classifieden_US
dc.subject.fieldofresearchcode119999en_US
dc.titleAtypical antipsychotic use for adult outpatients in New Zealand’s Auckland and Northland regionsen_US
dc.typeJournal articleen_US
dc.type.descriptionC1 - Peer Reviewed (HERDC)en_US
dc.type.codeC - Journal Articlesen_US
gro.rights.copyright© 2006 New Zealand Medical Association. The attached file is reproduced here in accordance with the copyright policy of the publisher. Please refer to the journal's website for access to the definitive, published version.en_US
gro.date.issued2006
gro.hasfulltextFull Text


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record